Status:
UNKNOWN
Urine VEGF Levels in Very Low Birth Weight (VLBW) Infants
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Infant, Very Low Birth Weight
Eligibility:
All Genders
Up to 32 years
Brief Summary
VLBW infants are at risk of developing retinopathy of prematurity (ROP). In the first phase of ROP there is a down-regulation of retinal VEGF-expression because of postnatal relative hyperoxia, follow...
Eligibility Criteria
Inclusion
- gestational age \< 32 weeks
- birth weight \<1500g
Exclusion
- absent written consent by parents
- connatal eye malformation
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00799721
Start Date
August 1 2008
End Date
December 1 2010
Last Update
December 1 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité Virchow-Hospital
Berlin, State of Berlin, Germany, 13353